Category: <span>stage IV mesothelioma</span>

Extending Late-Stage Mesothelioma Survival with Light Energy

Thoracic surgeon Dr. Joseph Friedberg and his colleagues identified a subset of patients with pleural mesothelioma who achieved a median overall survival of 7.3 years — an impressive survival compared to the usual one-year prognosis. The findings, which were published recently in The Annals of Thoracic Surgery, stemmed from a retrospective study that detailed significant…

The post Extending Late-Stage Mesothelioma Survival with Light Energy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.